AVR 0.08% $12.19 anteris technologies ltd

"Take a Closer Look", page-689

  1. 2,417 Posts.
    lightbulb Created with Sketch. 390
    Hey suckii, once again .... admire your passion, your perspective and view is also welcome, but it's gonna be a long hard slog for this company.

    That besides the immunotherapies division (issues: long term funding and likelihood of success) just seriously wondering at how fast will take off be in regards to the companies new products, posters I believe may be inclined, imo, to once again have inflated expectations of this.

    First there was the countdown of the medical centres using the CardioCel and now the countdown of the company's new products coming on line. Would be great to see this go gang busters but what will the reality be?

    The CardioCel took how long? Allowing for Code Red, restructuring and refocusing on the way forward and the traction CardioCel has gained WILL the new products be guaranteed much greater success|acceptence in the immediate/medium term?

    Admedus ... a global heavyweight, took that with a wry smile mate! Think we all know what that would take, the sp of 3 cents is hardly indicative of this!

    In regards to whether it was better to hear the webinar or see it ..... the latter, body language, imo, conveys way more than the spoken word. Remember how posters actually spoke of WP s body language from the last webinar!
    Last edited by iceman.11: 09/05/17
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.